Wayland Receives Additional Licensing from Health Canada
TORONTO, ON, December 24, 2018 – Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to announce that as of December 21, 2018 the Company has received additional licensing for seven (7) additional grow rooms from Health Canada, for phase one of its purpose-built cannabis production facility in Langton, ON.
Over the next 4 weeks the Company will transition 21,900 vegetative plants into the newly licensed rooms, three of which will be used for one cycle of flower, after which they will be used to support a perpetual cycle of cultivation as vegetation rooms.
“When the Company set out on this journey, one of our core objectives was to set the standard for high quality, large scale production of cannabis that consumers can trust. Our world class facility is one step closer to accomplishing that goal as we are now able to commence the perpetual cycle of cultivation. We are confident in the AI Data Grow platform developed in conjunction with Rockwell Automation, with proof of concept now complete. Full control of all aspects of cultivation from lighting, fertigation, nutrient cycles, temperature, humidity, and airflow is now in place, making quality of supply consistent and predictable.” Commented Ben Ward, CEO of Wayland.
An additional ten (10) flower rooms totaling 94,500 square feet have yet to be completed and will require Health Canada licensing approvals before cultivation can commence in those areas.
Maricann Group Inc., through its subsidiaries, is operating under the Wayland Group name. For further details see the press release dated September 24, 2018.
About Wayland Group
Wayland is a vertically integrated cultivator and processor of cannabis. The Company was founded in 2013 and is based in Burlington, Ontario, Canada and Munich, Germany, with production facilities in Langton, Ontario where it operates a cannabis cultivation, extraction, formulation, and distribution business under federal licenses from the Government of Canada. The Company also has production operations in Dresden, Saxony, Germany, Regensdorf, Switzerland, Allesandria, Piedmont, Italy, Ibague, Colombia, London, UK, Australia, and Argentina. Wayland will continue to pursue new opportunities globally in its effort to enhance lives through cannabis.
Forward Looking Statements
This news release includes forward-looking information and statements, which may include, but are not limited to, information and statements regarding or inferring the future business, operations, financial performance, prospects, and other plans, intentions, expectations, estimates, and beliefs of the Company. Such statements include those relating to the ability of the company to complete further development of further grow rooms, the cycle of plant growth, as well as the potential revenue and profit of the Company. Forward-looking information and statements involve and are subject to assumptions and known and unknown risks, uncertainties, and other factors which may cause actual events, results, performance, or achievements of the Company to be materially different from future events, results, performance, and achievements expressed or implied by forward-looking information and statements herein. Such assumptions include those related to the development of further growth rooms and the cycle of plant growth. Although the Company believes that any forward-looking information. Any forward-looking information and statements herein are made as of the date hereof, and except as required by applicable laws, the Company assumes no obligation and disclaims any intention to update or revise any forward-looking information and statements herein or to update the reasons that actual events or results could or do differ from those projected in any forward looking information and statements herein, whether as a result of new information, future events or results, or otherwise, except as required by applicable laws.
The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.
For more information about Wayland, please visit our website at www.waylandgroup.com
Contact Information: Investor Relations Graham Farrell VP, Communications Graham.Farrell@waylandgroup.com 647-643-7665
Media Inquiries: email@example.com
Corporate Headquarters (Canada) Wayland Group Corp. (Toronto) 845 Harrington Court, Unit 3 Burlington Ontario L7N 3P3 Canada 289-288-6274 European Headquarters (Germany) Maricann GmbH Thierschstrasse 3, 80538 Munchen, Deutschland